United States · FDA National Drug Code directory
Levalbuterol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81894-102_29ead193-b33d-7f78-e063-6294a90a7ef4
- Product NDC
- 81894-102
- Form
- SOLUTION
- Composition / generic term
- Levalbuterol
- Labeler
- Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161230
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVALBUTEROL HYDROCHLORIDE — .63 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 POUCH in 1 CARTON (81894-102-25) / 5 VIAL, SINGLE-DOSE in 1 POUCH (81894-102-05) / 3 mL in 1 VIAL, SINGLE-DOSE · 81894-102-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →